FDA

The risk-benefit ratio was deemed ‘acceptable’ even though more adverse events, including deaths, occurred in the drug treatment group.

The company said an inspection at a warehouse found that the bottles are ‘prone to breakage’ and may present a safety hazard.

Despite the proven efficacy of ivermectin in treating COVID-19, some studies in top-tier journals have concluded otherwise. Which data should we trust?

Philipp Kruse, who specializes in international law, has examined, line by line, the new WHO’s pandemic treaty and amendments to the Intl. Health Regulations.

The FDA has settled a lawsuit surrounding ivermectin and has agreed to remove posts telling people not to take ivermectin to treat or prevent COVID-19.

Humans may not fully appreciate the real benefits and values of nature, including its role in preventing epidemics.

Today, we’re diving into a mix of legal, political, and health news that’s shaping the nation. From courtroom battles involving high-profile figures to controve

A notice said there were 129 ’serious injuries’ that were reported, too.

The FDA issued a warning that veterinarians and pet owners should be alert for any unusual pet behavior in connection to recalled eyedrops.

Is the FDA secretly funding non-profits to lobby?

Federal agencies are canceling research, differing significantly from Europe’s more precautionary approach to cellphones.

The FDA approved the claim, reversing previous denial and despite some evidence flaws.

In the original three-year phase-out announcement in 2020, the FDA stated it could take about 18 months for PFAS-containing products to leave circulation.

Recent studies find oral decongestant phenylephrine ineffective, posing dilemma for FDA. Reform may be needed in the OTC drug approval process.